Literature DB >> 19911857

Diuretics in heart failure: a critical appraisal of efficacy and tolerability.

Anita D Szady1, James A Hill.   

Abstract

Heart failure is a significant cause of morbidity and mortality worldwide. While the aetiology varies and there are a wide variety of treatment options, a large amount of the morbidity related to heart failure is due to fluid retention and the symptoms of volume overload. Multiple neurohormonal pathways are activated in heart failure, and contribute to the symptoms of fluid retention and volume overload. Although not ideal, diuretic therapy is one of the mainstays of treatment of fluid overload in patients with heart failure. This review focuses on the pathophysiology of heart failure leading to volume overload, the different classes of diuretics used in alleviating the symptoms of fluid retention, their mechanisms of action within the kidney, and strategies for using them in ways that minimize their deleterious effects in patients with heart failure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19911857     DOI: 10.2165/11319920-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  30 in total

1.  Diuretic therapy and resistance in congestive heart failure.

Authors:  D H Ellison
Journal:  Cardiology       Date:  2001       Impact factor: 1.869

2.  Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.

Authors:  T P Dormans; J J van Meyel; P G Gerlag; Y Tan; F G Russel; P Smits
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

3.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Authors:  K Swedberg; P Eneroth; J Kjekshus; L Wilhelmsen
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

Review 4.  Sodium and water retention in heart failure and diuretic therapy: basic mechanisms.

Authors:  Domenic A Sica
Journal:  Cleve Clin J Med       Date:  2006-06       Impact factor: 2.321

5.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.

Authors:  M A Konstam; M F Rousseau; M W Kronenberg; J E Udelson; J Melin; D Stewart; N Dolan; T R Edens; S Ahn; D Kinan
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

6.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.

Authors:  M A Konstam; M W Kronenberg; M F Rousseau; J E Udelson; J Melin; D Stewart; N Dolan; T R Edens; S Ahn; D Kinan
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

7.  Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.

Authors:  Begoña López; Ramón Querejeta; Arantxa González; Eloy Sánchez; Mariano Larman; Javier Díez
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

Review 8.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

9.  Anti-aldosteronergic effect of torasemide.

Authors:  T Uchida; K Yamanaga; M Nishikawa; Y Ohtaki; H Kido; M Watanabe
Journal:  Eur J Pharmacol       Date:  1991-11-26       Impact factor: 4.432

10.  Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.

Authors:  D L Vargo; W G Kramer; P K Black; W B Smith; T Serpas; D C Brater
Journal:  Clin Pharmacol Ther       Date:  1995-06       Impact factor: 6.875

View more
  1 in total

1.  Fractional excretion of sodium predicts worsening renal function in acute decompensated heart failure.

Authors:  Fadi T Alattar; Nasha't Imran; Vincent A Debari; Kozhaya N Mallah; Fayez E Shamoon
Journal:  Exp Clin Cardiol       Date:  2010
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.